TITLE

Patients' Attitudes and Preferences About Participation and Recruitment Strategies in Clinical Trials

AUTHOR(S)
Sood, Amit; Prasad, Kavita; Chhatwani, Laveena; Shinozaki, Eri; Cha, Stephen S.; Loehrer, Laura L.; Wahner-Roedler, Dieteind L.
PUB. DATE
March 2009
SOURCE
Mayo Clinic Proceedings;Mar2009, Vol. 84 Issue 3, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE: To assess attitudes of patients about participation in clinical trials. PATIENTS AND METHODS: This is a self-report survey of 400 patients who underwent general medical evaluations between September and November 2006 at a tertiary care academic medical center in Rochester, MN. We measured knowledge of access to clinical trials, attitudes toward participation, recruitment preferences, and beliefs about research integrity. RESULTS: Of 485 consecutive patients, 400(82%) completed the survey. Previous participation in clinical trials was reported by 112 patients (28%). Most were unaware of online information about clinical trials (330 [82%]), were satisfied with their current knowledge (233 (58%]), expected their treating physician to inform them about current trials (304 [76%]), and showed equal interest in participating in conventional or complementary intervention trials (174 [44%]). Of the 400 respondents, 321 (80%) found it appropriate to be contacted by mail and 253 (63%) by telephone regarding study participation. Most patients (364 [91%]) wanted to be informed about research findings or else would not participate in future clinical trials (272 [68%]). The most frequently expected compensation was free parking (234 [58%]). Most thought that their safety (373 [93%]) and privacy (376 [94%]) would be guarded. CONCLUSION: Patients are interested in participating in clinical trials but commonly lack adequate information. If patients received more information (through their treating physicians), enrollment might improve. This single-site study has limited generalizability. Future studies involving a diverse group of patients from a broader geographic distribution will help provide more definitive results.
ACCESSION #
37147234

 

Related Articles

  • Challenges in Using Nonrandomized Studies in Systematic Reviews of Treatment Interventions. Norris, Susan L.; Atkins, David // Annals of Internal Medicine;6/21/2005 Supplement, Vol. 142, p1112 

    Randomized, controlled trials (RCTs) are firmly established as the standard for determining which medical treatments are effective. In some areas of health care, however, among them surgery, public health, and the organization of health care delivery, most evidence addressing the effectiveness...

  • A counterfactual approach to bias and effect modification in terms of response types. Etsuji Suzuki; Toshiharu Mitsuhashi; Toshihide Tsuda; Eiji Yamamoto // BMC Medical Research Methodology; 

    Background: The counterfactual approach provides a clear and coherent framework to think about a variety of important concepts related to causation. Meanwhile, directed acyclic graphs have been used as causal diagrams in epidemiologic research to visually summarize hypothetical relations among...

  • Cars, CONSORT 2010, and Clinical Practice. Williams, Hywel C. // Trials;2010, Vol. 11, p33 

    Just like you would not buy a car without key information such as service history, you would not "buy" a clinical trial report without key information such as concealment of allocation. Implementation of the updated CONSORT 2010 statement enables the reader to see exactly what was done in a...

  • AN ALTRUISTIC APPROACH TO CLINICAL TRIALS. Weinstein, James N. // Journal of Bone & Joint Surgery, American Volume;Jun2006, Vol. 88-A Issue 6, p1395 

    The article presents a reprint of the article "An Altruistic Approach to Clinical Trials: The National Clinical Trials Consortium (NCTC)," by James N. Weinstein, which appeared in the 2006 issue of the journal "Spine." The U.S. healthcare is irrationally distributed, and that patients in high...

  • Clinical trial for Fabry disease faces continuing hurdles. Silversides, Ann // CMAJ: Canadian Medical Association Journal;11/24/2009, Vol. 181 Issue 11, pE251 

    The article informs that the clinical trial for Fabry disease conducted by the Canadian Fabry Disease Initiative is facing problems because of the worldwide shortage of one of the enzyme replacement therapies. It is stated that the trial involves a comparison of the agalsidase beta (Fabrazyme)...

  • Observational Data Under the Microscope. Kubick, Wayne R. // Applied Clinical Trials;Apr2009, Vol. 18 Issue 4, p34 

    The article discusses the importance of using longitudinal health care data in clinical research in the U.S. It says that the data can be used in providing early warnings and assessment of potential safety issues, exploring and verifying safety signals of the patients, and for better...

  • Clinical Trials and Medical Care: Defining the Therapeutic Misconception. Henderson, Gail E.; Churchill, Larry R.; Davis, Arlene M.; Easter, Michele M.; Grady, Christine; Joffe, Steven; Kass, Nancy; King, Nancy M. P.; Lidz, Charles W.; Miller, Franklin G.; Nelson, Daniel K.; Peppercorn, Jeffrey; Rothschild, Barbra Bluestone; Sankar, Pamela; Wilfond, Benjamin S.; Zimmer, Catherine R. // PLoS Medicine;Nov2007, Vol. 4 Issue 11, pe324 

    A key component of informed consent to participate in medical research includes understanding that research is not the same as treatment.

  • The Tinnitus Research Initiative (TRI) database: A new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. Landgrebe, Michael; Zeman, Florian; Koller, Michael; Eberl, Yvonne; Mohr, Markus; Reiter, Jean; Staudinger, Susanne; Hajak, Goeran; Langguth, Berthold // BMC Medical Informatics & Decision Making;2010, Vol. 10 Issue 1, p42 

    Tinnitus, the phantom perception of sound, is a frequent disorder that causes significant morbidity and treatment is elusive. A large variety of different treatment options have been proposed and from most of them some patients benefit. However, a particular treatment that helps one patient may...

  • RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. Curtis, J. R.; Westfall, A. O.; Cheng, H.; Saag, K. G.; Delzell, E. // Osteoporosis International;Jun2009, Vol. 20 Issue 6, p973 

    The comparative effectiveness of alendronate and risedronate has received limited evaluation. Among 19,063 new users of bisphosphonates, risedronate users had a higher relative rate of hip fracture compared to alendronate users, but the difference in absolute fracture rate was small. We conclude...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics